Febuxostat inhibits non‑small cell lung cancer cell proliferation under starvation conditions by modulating xanthine oxidoreductase‑associated autophagy
It is demonstrated that XOR is involved in the metabolic drive of NSCLC progression under nutrient-deprived conditions and exerted anticancer effects by blocking XOR‑mediated pathways and suppressing protective autophagy, suggesting that repurposing FBX for NSCLC therapy warrants further preclinical investigation.